Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis

BACKGROUND & OBJECTIVES: Hydroxychloroquine (HCQ), reported to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in in vitro studies, has been recommended for prophylaxis of COVID-19 in healthcare workers (HCWs). The objective of this study was to assess short-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Faruqui, Atiya R., Xavier, Denis, Kamat, Sandhya K., Chandy, Sujith J., Medhi, Bikash, Tripathi, Raakhi K., Shetty, Yashashri C., Raj, John Michael, Kaushal, Sandeep, Balakrishnan, S., Atal, Shubham, Tripathi, Santanu K., Badyal, Dinesh K., Dikshit, Harihar, Roy, Sukalyan Saha, Trivedi, Niyati, Chatterjee, Suparna, Desai, Chetna, Tripathi, C.D., Rege, Nirmala N., Gupta, Pooja, Raveendran, R., Kaul, Rajni, Kshirsagar, Nilima A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Programme
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184065/
https://www.ncbi.nlm.nih.gov/pubmed/33818480
http://dx.doi.org/10.4103/ijmr.IJMR_2294_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184065/
https://www.ncbi.nlm.nih.gov/pubmed/33818480
http://dx.doi.org/10.4103/ijmr.IJMR_2294_20

Ejemplares similares